nice guidance released., page-2

Not great.

NHS in the UK ain't going to be using this as a replacement for meshed skin grafting until the company completes a clinical trial in the area.

"1.1 The ReCell Spray-On Skin system shows potential to improve healing in acute burns. However there is insufficient evidence on its use in clinical practice, particularly in relation to which patients might benefit most from its use, to support the case for its routine adoption in the NHS."

"1.2 Research is recommended to address uncertainties about the claimed patient and system benefits of the ReCell Spray-On Skin system. The research should include time to 95% healing, length of hospital stay, cosmetic appearance of the scar and function of the burned area, compared against standard care. The research might include analysis of data generated from existing databases and registers. NICE will explore the development of appropriate further evidence, in collaboration with the technology sponsor and with clinical and academic partners, and will review this guidance when new and substantive evidence becomes available."